#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12744	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2302	547.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1427	1427	C	684	C,A	659,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12744	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2302	547.6	0	HET	.	.	.	C207T	.	207	207	C	450	450	C	798	C,T	598,159	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12744	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2302	547.6	0	HET	.	.	.	C451T	.	451	451	C	694	694	C	736	C,T	528,181	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23556	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3657	640.3	0	.	n	.	0	T695C	SNP	695	695	T	1104	1104	C	720	C	694	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23556	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3657	640.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2380	2380	C	748	C	708	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23556	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3657	640.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2454	2454	A	765	A	736	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23556	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3657	640.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3006	3006	C	695	C	665	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1590	folP	855	855	100.0	folP.l15.c4.ctg.1	1431	109.9	1	SNP	p	R229S	1	.	.	685	687	AGC	955	957	AGC	172;173;172	A;G;C	160;160;158	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4146	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3368	122.2	1	SNP	p	S91F	1	.	.	271	273	TTC	599	601	TTC	150;148;152	T;T;C	145;143;147	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4146	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3368	122.2	1	SNP	p	G95N	0	.	.	283	285	GGC	611	613	GGC	151;149;148	G;G;C	146;143;143	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4146	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3368	122.2	1	SNP	p	D95G	1	.	.	283	285	GGC	611	613	GGC	151;149;148	G;G;C	146;143;143	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1400	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1319	105.5	1	SNP	p	G45D	0	.	.	133	135	GGC	436	438	GGC	167;166;167	G;G;C	163;162;161	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	714	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1027	68.8	0	.	n	.	0	A197.	DEL	197	197	A	599	599	A	156	A	151	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	3960	parC	2304	2304	99.96	parC.l15.c30.ctg.1	3011	130.4	0	.	p	.	0	P269S	NONSYN	805	807	CCG	1167	1169	TCG	156;155;155	T;C;G	147;147;147	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	3960	parC	2304	2304	99.96	parC.l15.c30.ctg.1	3011	130.4	1	SNP	p	D86N	0	.	.	256	258	GAC	618	620	GAC	156;156;155	G;A;C	151;145;150	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	3960	parC	2304	2304	99.96	parC.l15.c30.ctg.1	3011	130.4	1	SNP	p	R87I	0	.	.	259	261	CGT	621	623	CGT	158;156;159	C;G;T	153;151;154	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	3960	parC	2304	2304	99.96	parC.l15.c30.ctg.1	3011	130.4	1	SNP	p	S87R	1	.	.	259	261	CGT	621	623	CGT	158;156;159	C;G;T	153;151;154	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	3960	parC	2304	2304	99.96	parC.l15.c30.ctg.1	3011	130.4	1	SNP	p	R87W	0	.	.	259	261	CGT	621	623	CGT	158;156;159	C;G;T	153;151;154	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	3960	parC	2304	2304	99.96	parC.l15.c30.ctg.1	3011	130.4	1	SNP	p	S88P	0	.	.	262	264	TCC	624	626	TCC	158;158;158	T;C;C	153;154;153	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3370	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2618	128.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1505	1507	GGC	154;152;152	G;G;C	153;151;150	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3638	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	152.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1207	1209	GCC	196;195;196	G,A;C,T;C	190,1;191,1;192	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3638	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	152.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1210	1212	ATG	199;198;194	A;T;G	196;195;190	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3638	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	152.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1222	1224	ACC	198;199;198	A;C;C	190;193;193	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3638	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	152.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1222	1224	ACC	198;199;198	A;C;C	190;193;193	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3638	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	152.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1723	1725	ACC	187;188;187	A;C;C	180;185;182	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3638	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	152.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1777	1779	GCG	183;184;186	G;C;G	175;176;178	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3638	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	152.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1777	1779	GCG	183;184;186	G;C;G	175;176;178	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3638	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	152.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1900	1902	GGT	155;154;150	G;G;T	150;150;142	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3638	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	152.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1909	1911	AGC	151;147;147	A;G;C	142;140;137	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3638	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2377	152.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1927	1929	CCG	122;120;118	C,G;C,G;G	112,2;108,1;105	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4882	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3215	150.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1671	1673	CCG	170;166;166	C;C;G	158;158;155	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1650	porA	1146	1146	99.91	porA.l6.c30.ctg.1	1716	95.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	574	574	C	101	C	94	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	236	porB1a	984	275	90.68	porB1a.l15.c30.ctg.1	553	12.6	0	.	p	.	0	H217N	NONSYN	649	651	CAT	303	305	AAT	12;12;12	A;A;T	12;11;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	236	porB1a	984	275	90.68	porB1a.l15.c30.ctg.1	553	12.6	0	.	p	.	0	D218N	NONSYN	652	654	GAT	306	308	AAT	12;12;12	A;A;T	12;11;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	236	porB1a	984	275	90.68	porB1a.l15.c30.ctg.1	553	12.6	0	.	p	.	0	V226A	NONSYN	676	678	GTA	330	332	GCA	9;9;9	G;C;A	8;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	236	porB1a	984	275	90.68	porB1a.l15.c30.ctg.1	553	12.6	0	.	p	.	0	.	MULTIPLE	700	702	ACT	353	355	GTA	9;9;9	G;T;A	8;8;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	236	porB1a	984	275	90.68	porB1a.l15.c30.ctg.1	553	12.6	0	.	p	.	0	N237fs	FSHIFT	709	709	A	362	362	A	10	A	10	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2706	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1544	173.9	0	.	p	.	0	E209K	NONSYN	625	627	GAA	927	929	AAA	221;225;230	A;A;A	217;221;227	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2706	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1544	173.9	0	.	p	.	0	A212E	NONSYN	634	636	GCA	936	938	GAA	216;213;213	G;A,G;A	213;207,1;208	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2706	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1544	173.9	1	SNP	p	G120K	1	.	.	358	360	AAG	660	662	AAG	200;200;204	A,C;A;G	188,2;193;194	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2706	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1544	173.9	1	SNP	p	N121D	0	.	.	361	363	AAC	663	665	AAC	207;205;206	A,G;A;C	202,1;200;199	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2706	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1544	173.9	1	SNP	p	A121N	1	.	.	361	363	AAC	663	665	AAC	207;205;206	A,G;A;C	202,1;200;199	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9500	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4917	192.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1102	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1009	107.4	1	SNP	p	V57M	1	.	.	169	171	ATG	501	503	ATG	221;221;222	A;T,C,A;G	213;209,1,1;215	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
